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ABSTRACT 
The Relationship Between Myocardial Blood Flow Reduction 
and Heterogeneity of Ischemic Injury 
Following Experimental Coronary Artery Occlusion 
in the Canine Model 
Mark Ian Block 
1987 
Early in the evolution of a myocardial infarction there 
is heterogeneity of ischemic injury within the region 
supplied by the occluded artery. To examine the 
relationship between morphologically-delineated myocardial 
injury and blood flow reduction nine closed-chest 
anesthetized dogs were studied during a three hour left 
anterior descending (LAD) coronary artery occlusion. The 
"area at risk" was delineated by injection of monastrel blue 
dye into the left ventricle (LV) immediately prior to 
sacrifice. Ischemic, glycogen depleted zones were 
identified by periodic acid-Schiff staining of giant 
histologic sections, and necrotic zones by gross tetrazolium 
staining. Prior to and following LAD occlusion, regional 
blood flow was measured by injection of 15-um diameter 
radionuclide labeled microsperes into the LV. Three 
overlapping zones were delineated: 1) A necrotic zone (12 + 
13% of LV, mean + S.D.), within 2) an ischemic zone (27 + 
9% of LV), within 3) an underperfused zone (33 + 8% of LV). 
Blood flows at 20 minutes after occlusion were similar to 
those measured at three hours. In necrotic tissue, blood 
flow at three hours was 6+3 (ml/min/lOOgm + S.E.M.). In 
ischemic but not necrotic tissue, flow was 26+3, and in 
tissue that was only underperfused, flow was 68+5. Flow 

in normal myocardium was 88+6. Thus, during the evolution 
of infarction, attenuation in blood flow from 20 minutes to 
three hours after occlusion is not found, and the 
quantifiable gradient of reduced blood flow in the "risk" 
region is reflected in morphologically demonstrable 
heterogeneity of injury which at 3 hours includes a zone of 
necrosis, ischemia without necrosis, and underperfusion 
without evidence of ischemic injury. 
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INTRODUCTION 
Background: 
Convincing evidence that a variety of interventions can 
influence the extent of myocardium rendered irreversibly 
injured following experimental coronary artery occlusion 
(19,71-73,76,90,111) has led to acceptance into clinical 
practice of the importance of restoring blood flow to 
ischemic tissue (22,35,93). Studies of early reperfusion in 
experimental animals have consistently demonstrated 
reduction in subseguent myocardial infarct size with 
concomitant restoration in ventricular function. With 
reperfusion following a three hour left anterior descending 
(LAD) coronary artery occlusion in the canine model, Maroko 
et al. (71) used enzymatic, histologic and functional 
criteria to illustrate salvage of myocardial tissue. In a 
similar model, Costantini, et al. (19) found recovery of 
ventricular function to near pre-occlusion levels with 
limitation of infarct size to less than 50% of that found in 
non-reperfused animals. Similar studies in primates have 
yielded similar results (49) and reports of reduction of 
ischemic bed size in the dog with counterpulsation (intra¬ 
aortic balloon pump) (111) and medical therapy (88) have 
contributed to an appreciation for the heterogeneity of 
injury within the ischemic bed. These results suggest that 
the "area at risk" is composed of irreversibly as well as 
reversibly injured tissue, and that early therapeutic 
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intervention can salvage otherwise doomed myocardium. 
Although experimental evidence is strong, several 
randomized and non-randomized clinical studies have provided 
inconsistent results concerning the effects of reperfusion 
on myocardial performance and patient mortality 
(58,75,89,94,95). In a review of the literature, Rentrop 
(94) found that only one of five controlled trials 
demonstrated statistically significant inprovement in left 
ventricular function from the acute to the chronic stage 
following streptokinase therapy (71), and that of these same 
five trials only one showed statistically significant 
improvement in mortality (58). 
To better understand the pathophysiology underlying the 
effect of reperfusion on myocardial infarction and bridge 
the gap between experimental evidence and clinical results, 
investigators have focused on the heterogeneity of injury 
within the myocardium at risk (30,88,90,113,114). Hearse et 
al. (43) demonstrated gradients of biochemical change at 
the margins of evolving infarcts, and Reimer et al. (90,91) 
described a region of myocardium surrounding the central 
ischemic zone which exhibits functional, histologic and 
ultrastructural changes consistent with reversible injury, 
and which progresses in a "wavefront" phenomenon to eventual 
irreversible injury and necrosis following prolonged 
ischemia. In the primate model, the area of ischemia has 
similarly been found to increase during the first three to 
four hours of coronary artery occlusion, with early muscle 
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necrosis extending outward in a concentric fashion from a 
small, centrally located subendocardial region, to 
"progressively involve an initially larger peripheral zone 
of ischemic, nonfunctional, but potentially viable 
myocardium" (49). 
Myocardial Metabolism; 
Normal myocardium is highly dependent on oxidative 
metabolism, extracting up to 75% of the arterial oxygen 
content. In the well oxygenated heart, free fatty acid 
(FFA) oxidation can account for as much as 90% of oxidative 
phosphorylation (7,106), and represents the primary 
contributor to energy production (65,104). Other substrates 
include glucose, pyruvate and lactate. Excess glucose is 
stored as glycogen, and excess FFA's are stored as cardiac 
lipid (esterified fatty acids). 
Dependence of myocardial metabolism on oxidative 
pathways is reflected in the relatively low concentration of 
anaerobic enzymes compared to the cytochromes and abundant 
mitochondria. In the presence of adequate oxygen, 
conversion of low energy ADP to high energy ATP during 
electron transport is fueled by the reduced flavin and 
nicotine enzymes (FAD, NAD and NADP) produced by the citric 
acid cycle (Kreb's cycle) dehydrogenations (104). The 
resulting high yield of ATP is required for continued 
organized contraction of the myocardium (53) by both fueling 
actin-myosin interactions and supporting transmembrane 
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electrical potentials dependent on Na/K ATPases (104). 
Hypoxia interferes with normal oxidative 
phosphorylation in myocardial mitochondria and reduces ATP 
formation by electron transport (104). As cardiac metabolism 
shifts to the less efficient anaerobic production of ATP 
through glycolytic pathways, high energy phosphate levels 
fall rapidly and significantly (13), and within seconds 
contractile dysfunction can be observed (44,59,65,113). 
Conversion of fructose-l-phosphate to fructose-1,6- 
diphosphate is accelerated by the increased concentrations 
of ADP and AMP, placing increased demand on the hexokinase 
conversion of glucose to glucose-6-phosphate (65). The 
resulting increased utilization of glucose leads to 
activation of glycogen phosphorylase with subsequent 
glycogenolysis and depletion of myocardial glycogen stores 
(52). Dependence on glycolysis for energy production also 
lowers intracellular pH through the production of lactate 
(111,121). Utilization of FFA's is the most sensitive to 
oxygen deprivation, with inhibition of the electron 
transport chain preventing the beta-oxidation of FFA's by 
+ 
increasing the cytosolic NADH/NAD ratio (65). Accumulation 
of fatty acyl derivatives ensues (7). Hypoxia thus leads to 
increased glucose utilization, depletion of myocardial 
glycogen stores, cellular acidosis and deposition of fatty 
acids. Prolongation of the hypoxic insult results in 
irreversible ischemic injury and necrosis, with subsequent 
demonstrable loss of cellular enzymes (5,9,27,30,31,45,110). 
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Experimental Evaluation of Ischemic Injury; 
Histochemical techniques exploit differences in 
myocardial metabolism under normal and hypoxic conditions 
and enable the localization of biochemical gradients both 
morphologically and topographically. Their application to 
experimentally induced myocardial infarction reveals the 
early existence of three distinct zones within the area at 
risk (30): 1) A central zone of severe glycogen and enzyme 
loss; 2) A peripheral zone of severe glycogen loss with 
only mild enzyme loss; and 3) A lipid containing but 
otherwise histochemically normal zone. These observations 
coincide with the above described ischemic changes in 
myocardial metabolism and further support the conclusion 
that the area at risk is composed of regions subjected to 
varying degrees of blood flow reduction with subsequent 
regional variability in the hypoxic insult (53). 
Positron emission tomographic (PET) studies have 
provided a method for the noninvasive assessment of regional 
myocardial metabolism in comparison to the relative 
reduction in regional myocardial blood flow 
(82,102,107,108,120). These studies demonstrate the 
existence of a region of mild ischemia in which uptake and 
clearance of labeled metabolites (primarily C-ll palmitate, 
a long chain fatty acid avidly extracted from the 
circulation by the heart) are distinctly different from 
uptake and clearance in both the central ischemic zone and 
distant normal myocardium. The metabolic abnormality is one 
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of fatty acid metabolism, a finding that corresponds to its 
understood sensitivity to hypoxia and the observed 
histologic evidence of lipid deposition in segments with 
only little flow reduction (110). 
With the advent of radiolabeled microspheres (98), 
regional myocardial perfusion can be evaluated at a variety 
of time intervals with an accuracy and resolution not 
otherwise achieveable (17,32,53,112). Although 
investigators have used this technique to correlate regional 
blood flow with functional (38,99,101,121) and histologic 
(33,34,47,50,97,101,122) evidence of injury, gradients 
present between histochemically distinct regions of the area 
at risk and the early temporal changes in regional perfusion 
following coronary artery occlusion have not been clearly 
established. Bishop, et al. (8), documented severe 
reductions in blood flow at the center of the ischemic zone, 
with less severe reductions at the epicardial and lateral 
margins of the infarct. Identificaton of ischemic tissue was 
based on histologic appearance, and no attempt was made at 
using histochemical techniques to divide the area at risk 
into regions of varying ischemic injury. Rivas, et al. (97) 
used microspheres to demonstrate similar flow patterns in 
myocardium subjected to 6 days of ischemia. With a sharply 
demarcated area of necrosis following such prolonged 
ischemia, it is difficult to assess the regional perfusion 
during the "wavefront" progression of infarction that ocurrs 
within the first hours following coronary artery occlusion. 
. 
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In an attempt to quantify blood flow during this critical 
period of early ischemia, Hearse, et al. (43) studied 
perfusion at 21 and 26 minutes of ischemia. Identification 
of varying degrees of ischemic injury was accomplished by 
evaluating the composition of various metabolites in tissue 
biopsies taken from sites across the ventricular surface 
designed to include the margins of the evolving infarct. By 
comparing tissue content of lactate, ATP, creatine phosphate 
and glycogen with measures of flow by the microsphere 
technique, they concluded that the extent of metabolic 
abnormality was "directly related to the degree of ischemia, 
as indicated by the reduction in coronary flow." 
These and similar studies of blood flow following 
coronary artery occlusion (116) have demonstrated the 
presence of an intermediate zone of perfusion between the 
central necrotic and distant normal tissue. As discussed 
above, early in the evolution of a myocardial infarct this 
intermediate zone can be divided histochemically into three 
different regions representing different degrees of ischemic 
injury. By combining microsphere techniques with 
histochemistry, it is the goal of this study to characterize 
the early regional perfusion deficits in all three 
histologic zones. A three hour left anterior descending 
coronary artery balloon occlusion in the anesthetized dog is 
used because it has been shown to represent a critical early 
period in the evolution of a myocardial infarction and 
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produces clear morphologic distinctions between the 
present within the area at risk. 
zones 
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MATERIALS AND METHODS 
Animal Preparation and Instrumentation: 
In nine adult mongrel dogs weighing between 20 and 30 
kgs. induction of anesthesia was accomplished with sodium 
thiamylal (surital) and, following endotracheal intubation, 
maintained with a mixture of halothane (0.3 to 0.5%), oxygen 
and room air to insure a partial pressure of oxygen above 
100 mm Hg. The dogs were then placed in the right lateral 
decubitus position and the right and left femoral arteries 
were exposed and cannulated through small incisions. Under 
fluoroscopic guidance a 7-French pigtail catheter was 
introduced through the right femoral artery into the apex 
of the left ventricle to be used for injection of 
microspheres and monastrel blue dye and for hemodynamic 
monitoring. Similarly a 7-French catheter was advanced into 
the left femoral artery for arterial blood sampling 
purposes. 
The left carotid artery was exposed and cannulated 
through a small incision. A 7-French catheter was advanced 
under fluoroscopic guidance into the ostium of the left 
anterior descending (LAD) coronary artery through which a 5- 
French Fogarty balloon catheter was inserted. The balloon 
tip was placed distal to the first diagonal visualized by 
contrast medium injection. The balloon was inflated with a 
mixture of saline and contrast medium and occlusion of the 
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LAD was verified by a repeated injection of contrast medium. 
Arterial pressure and ECG were monitored continuously using 
a strip chart recorder (Brush 200, Gould Inc., Cleveland, 
Ohio). Prior to occlusion of the LAD, lidocaine was 
administered intravenously in a 50 mg. bolus with subsequent 
infusion at a rate of 1 mg./min. in a saline drip. 
Experimental Design: 
Complete occlusion of the LAD for three hours was 
effected by balloon inflation and verified by repeated 
injection of contrast medium. Radiolabeled microspheres 
were injected through the left ventricular catheter at three 
intervals: 1) Prior to occlusion, 2) approximately 20 
minutes after initiation of occlusion, and 3) prior to 
sacrifice at approximately three hours after initiation of 
occlusion. Monastrel blue dye (0.5 ml/kg) was injected 
through the left ventricular catheter immediately prior to 
sacrifice which was accomplished by injection of 2 ml of a 
saturated solution of KC1 through the same catheter. A left 
thoracotomy was then performed and the heart exposed. At 
the onset of ventricular fibrillation the balloon catheter 
was withdrawn from the LAD and the heart excised by 
transection of the great vessels, vena cavae and pulmonary 
veins. 
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Regional Myocardial Blood Flow: 
Regional myocardial blood flow was determined with 
radiolabeled microspheres by using the arterial reference 
withdrawal method (46). For each flow determination 
6 
approximately 3 x 10 15-um diameter microspheres, labeled 
with one of three different isotopes ■— Cobalt-57, Scandium- 
46 or Tin-113 (3M Company) — were added to 5 to 6 ml of 
heparinized blood, vortexed and ultrasonicated to insure 
adequate suspension, and immediately injected through the 
left ventricular catheter over 10 to 20 seconds. Placement 
of the catheter tip in the apex of the left ventricle was 
verified by fluoroscopy. A Harvard pump was used for 
withdrawal of the arterial reference sample at a constant 
rate of 7.9 ml/min through the left femoral artery catheter 
for a total of 2 minutes. 
For a complete discussion of the radionuclide labeled 
microsphere technique see appendix III. 
Postmortem Tissue Analysis: 
Immediately following sacrifice the excised heart was 
divided transversely (parallel to the coronary sinus) into 
five ventricular slices labeled one to five from apex to 
base (see fig. 1). The apical slice (slice 1) measured ~1.5 
cms. with the remaining four -1.0 cm in thickness. Slices 
two and four were immediately placed in Carnoy's fixative 
(60% absolute alcohol, 30% chloroform and 10% acetic acid) 
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for later giant sectioning and staining with periodic acid- 
Schiff stain (PAS) as described below. Using monastrel blue 
dye distribution to delineate the underperfused zone, 
biopsies for electron microscopy were taken from sites on 
the apical side of slice three, divided into approximate 1 
3 
mm pieces and placed in cold 3% glutaraldehyde fixative 
within three minutes of sacrifice. Three to four samples 
were taken from the center of the underperfused zone, from 
the lateral and epicardial margins, and from distant 
normally perfused myocardium. 
The remaining slices (one, three and five) were rinsed 
in sterile saline and photographed to document monastrel 
blue dye staining and location of biopsy sites. They were 
then incubated in fresh triphenyltetrazolium chloride (TTC) 
for 15 minutes and rephotographed to document non-staining, 
necrotic regions of the myocardium. Following photocopying 
of the slices for mapping purposes, the right ventricular 
free wall was removed and the septum and left ventricular 
free wall were divided transmurally into wedges which were 
subsequently divided into subendocardial, mesocardial and 
subepicardial segments, each weighing 0.5 to 1.0 gram. The 
boundaries of each numbered sample were indicated on the 
photocopy of each slice. Samples were then weighed and 
counted on a multichannel pulse-height gamma counter to 
quantitate radioactivity from each of the three isotopes. 
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Histoloqic Evaluations: 
ELECTRON MICROSCOPY: Samples for electron microscopy 
were fixed in glutaraldehyde overnight at 4° C, dehydrated, 
stained with osmium and embedded in epon. One micrometer 
thick sections were cut, stained with toluidine blue and 
examined by light microscopy to select regions for 
ultrastructural study. Thin sections were then cut from the 
selected regions, stained with uranyl acetate and lead 
citrate, and examined in a JEDL 100B transmission electron 
microscope for ultrastructural evidence of ischemic injury 
and presence or absence of lipid droplets. Using the 
postmortem photographs, each specimen could be assigned to a 
specific region of the myocardium and thus compared to the 
results of each additional investigation. 
TISSUE GLYCOGEN CONTENT: Following fixation in 
Carnoy's for at least five days, slices two and four from 
each dog were processed in absolute alcohol then Cedarwood 
oil, embedded in paraffin and giant sectioned as described 
previously (100). Delineation of myocardium containing 
glycogen was accomplished by staining with PAS. 
PLAINIMETRY: The photographic slides obtained of 
slices one, three and five before and after staining with 
TTC and the giant sections of slices two and four after 
staining with PAS were projected onto a rear projection 
theater screen for planimetry (Numonics Industrial 
Planimeter). This allowed regions devoid of monastrel blue 
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dye, TTC or PAS staining to be outlined and quantitated 
relative to the cross-sectional area of the entire left 
ventricle. Data from the apical and basal sides of each 
slice were combined to provide an expression for the area of 
respective injury as a percentage of total left ventricular 
myocardium in each slice. 
Data Correlation; 
Each sample from slices one, three and five was 
assigned a separate value of from 0 to 1 representing the 
extent of staining by monastrel blue dye, PAS and TTC. By 
comparing the photocopy and photographic slide of each 
slice, the location of each sample could be identified. 
This enabled the characterization of the extent of staining 
by monastrel blue dye and TTC for each sample. Similarly, 
values for staining by PAS were obtained by comparing the 
photocopies to the PAS stained giant sections. A separate 
value for each of the three stains was assigned to each 
sample, with 0 representing complete absence of staining 
(stain negative), and 1 representing homogeneous staining 
throughout the sample (stain positive). Inhomogeneity of 
staining was represented with values between 0 and 1, with 
an approximately equal division of a sample into stained and 
non-stained myocardium indicated with a value of 0.5. 
Values were determined by visual inspection and represent 
the consensus of two independent observers. 
. 
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Based on the assigned values for each of the three 
stains. samples were divided into seven groups -- four 
"pure" and three "mixed" ones. The "pure" groups consisted 
of 1) samples completely stained by all three stains 
(monastrel blue dye, PAS and TTC positive) -- normal 
myocardium; 2) samples monastrel blue dye negative but PAS 
and TTC positive — underperfused but not ischemic or 
necrotic; 3) samples monastrel blue dye and PAS negative 
but TTC postive — ischemic but not necrotic myocardium; and 
4) samples monastrel blue dye, PAS and TTC negative 
necrotic myocardium (see table 1). The remaining samples 
were assigned to the "mixed" groups based on their 
heterogeneity of staining (table 2). 
Statistical Analysis: 
Following division of the samples into groups, average 
flow (+ S.D.) for each group in each animal was calculated. 
Mean myocardial blood flow for all animals prior to 
occlusion, 20 minutes post-occlusion and 3 hours post¬ 
occlusion is expressed as mean + standard error for each of 
the four "pure" and three "mixed" groups. This represents 
the arithmetic mean of the individual averages calculated 
for each animal, and is therefore a "mean of means." A non- 
paired, two-tailed Student's t-test was used for statistical 
comparisons between population means. The significance 
level, or alpha, was set at 0.05 with p<0.05 considered 
statistically significant. 
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RESULTS 
Hemodynamics: 
In all nine dogs the left anterior descending coronary 
artery was successfully occluded for three hours. Blood 
pressure and heart rate were stable in all animals (table 
3). One animal was in ventricular bigeminy with a stable 
blood pressure at the time of the second microsphere 
injection (20 minutes post-occlusion) but returned to normal 
sinus rhythm before the third injection at three hours. No 
other animals developed cardiac arrhythmias. 
Histology, Zone Size and Regional Perfusion: 
Postmortem analysis identified a region of myocardium 
with normal staining characteristics which occupied 67 + 8% 
of the left ventricle. Perfusion of this region prior to 
occlusion was 114 + 12 ml/min/lOOgm. Following LAD occlusion 
this value fell to 98 + 13 ml/min/lOOgm at 20 minutes 
(p<0.4) and 88+6 ml/min/lOOgm after three hours (p<0.1). 
The area at risk, defined as the region of myocardium 
supplied by the occluded vessel, was visualized by the lack 
of staining with monastrel blue dye (fig. 2a) and 
represented 33 + 8% of the left ventricular cross-sectional 
area at the level of slice three. Preocclusion blood flow 
was 125 + 19 ml/min/lOOgm, while flows at 20 minutes and 
three hours were 32+6 ml/min/lOOgm (p<0.001) and 29 + 6 
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ml/min/lOOgm (p<0.001) respectively (table 4). 
The area at risk was further delineated into zones 
based on the results of TTC and PAS staining (figs. 2b and 
2c). Zone size was variable from animal to animal (table 5). 
The central necrotic zone was characterised by the absence 
of TTC staining and measured 12 + 13% of the left ventricle 
(range 0% to 35%). Regional perfusion was 126 + 13 
ml/min/lOOgm prior to occlusion and fell to 9 + 2 (p<0.001) 
and 4 + 2 ml/min/lOOgm (p<0.001) at 20 minutes and three 
hours following occlusion (n=4 dogs). The glycogen depleted 
(ischemic) but not necrotic zone (PAS negative, TTC 
positive) measured 15 + 9% of the left ventricle. 
Preocclusion flow was 141 ml/min/lOOgm. Flows after 20 
minutes and three hours of occlusion were 24 and 11 
ml/min/lOOgm respectively (n=l dog). The remaining 
myocardium within the area at risk was defined as 
underperfused without evidence of ischemia (blue dye 
negative, PAS and TTC positive) and occupied 7 + 8% of the 
left ventricle. Preocclusion, 20 minute and three hour 
flows were 163, 67 and 80 ml/min/lOOgm, respectively (n=l 
dog). (These data are summarized in table 6.) 
Utilizing the strictest criteria of complete presence 
or absence of staining for inclusion of samples into one of 
these groups limited the sample size in the latter two zones 
to tissue from only one dog. Given this limitation in 
sample size the criteria for inclusion into these groups 
were "expanded" to include those samples whose staining 
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pattern was evaluated as representing <20% and >80% of the 
tissue instead of 0% and 100% respectively. The resulting 
mean values for myocardial blood flow prior to occlusion and 
20 minutes and three hours post-occlusion are shown in table 
7 and illustrated in figure 3. 
Preocclusion flows in all four regions were comparable. 
Blood flow to the underperfused but not ischemic zone at 20 
minutes was less than flows to the normal zone (p<0.025). 
At the same time period, perfusion to the ischemic but not 
necrotic zone was less than to both the normal (p<0.001) and 
the underperfused but not ischemic zones (p<0.005), and 
greater than flow to the necrotic zone (p<0.2). Although 
flow in the necrotic zone at this time period was not 
statistically significantly lower than that observed in the 
ischemic but not necrotic zone, it represented the lowest 
value for myocardial perfusion and was statistically 
significantly different than flows in the normal myocardium 
(p<0.001) and the underperfused but not ischemic zone 
(p<0.025). 
Regional perfusion in all four zones at three hours 
remained similar to the values obtained at 20 minutes after 
occlusion; however, smaller confidence limits (or calculated 
S.E.M.) for the mean flows resulted in increasing 
statistical significance. Flow in the necrotic zone was the 
lowest, remaining less than in the ischemic but not necrotic 
zone (p<0.005), the underperfused but not ischemic zone 
(p<0.001) and the normal myocardium (p<0.001). Similarly, 
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flow in the ischemic but not necrotic zone, while greater 
than in the necrotic myocardium, continued to be lower than 
that observed in the underperfused but not ischemic zone 
(p<0.005) and the normal zone (p<0.001). Perfusion to the 
normal myocardium remained the highest (p<0.05 compared to 
the underperfused but not ischemic zone). 
The remaining samples were grouped into three "mixed" 
categories as outlined in table 2. For example, if an 
entire sample (100%) was stained with TTC, but PAS stained 
only 40% and monastrel blue dye staining was absent, this 
indicated "mixed" composition. Myocardium underperfused 
(blue dye negative) without evidence of ischemia (PAS 
positive) and tissue rendered ischemic (PAS negative) but 
not necrotic (TTC positive) were present in the same sample. 
The results of calculations of mean flow in these "mixed" 
groups are shown in table 8. Similar to results in the 
"pure" groups, regional perfusion was found to decrease with 
increasing histochemical evidence of ischemic injury. The 
inhomogeneity of staining in samples assigned to these 
groups indicates the possibility of widely disparate flows 
within the same sample and therefore prohibits more than 
qualitative analysis of the data. 
Electron Microscopy: 
In all cases transmission electron microscopy confirmed 
the results of our histochemical studies (54). Biopsies 
from normally stained segments of myocardium distant from 

-20- 
the territory of the LAD demonstrated normal myocardium with 
normal glycogen stores, devoid of edema, mitochondrial 
amorphous densities and lipid droplets (fig. 4a). Biopsies 
taken from regions of myocardium bordering ischemic tissue 
but not ischemic (based on PAS staining) demonstrated the 
presence of lipid droplets as the only abnormality. There 
were no ultrastructural changes consistent with ischemia 
(fig. 4b). Biopsy specimens from ischemic but not necrotic 
regions showed generally accepted evidence of reversible 
ischemic injury. This included mitochondrial and cellular 
swelling, wide I-bands and decreased glycogen stores (fig. 
4c). Electron microscopy of tissue taken from regions of 
myocardium demonstrated to be necrotic by the absence of TTC 
staining showed classical signs of necrosis. In addition 
to ischemic changes, the formation of mitochondrial 
amorphous densities, clumping and margination of nuclear 
chromatin, and disruption of sarcolemmal and mitochondrial 
membranes were observed (fig. 4d). 
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DISCUSSION 
The Canine Model: 
Much of the experimental data on myocardial infarction 
has been obtained in the dog, although several authors 
question the validity of its application to human disease 
(38,99,101). Unlike the coronary circulation of a normal 
human heart, the canine's is characterized by significant 
collateral vasculature (11,24,26,84). Consequently many 
investigators have chosen instead to study the effects of 
coronary artery occlusion in the pig (38,52,99,101), the rat 
(5,30,78,80) and the primate (49,61,76). While the normal 
human heart may posess few collaterals, experimental 
evidence for development of a collateral circulation 
following coronary artery occlusion (11) suggests that 
progression of atherosclerotic disease in man may lead to 
development of functionally significant anastomoses. 
Indeed, many authors have reported that not only are 
coronary collateral vessels commonly present in patients 
with coronary arteriosclerosis (6,42,62,79), but clinical 
and angiographic data indicate that they play a significant 
protective role in the presence of obstructive disease 
(39,123). While the canine model may not accurately 
reproduce conditions present in the normal human heart, 
there is considerable evidence to suggest that acute 
occlusions in the dog may adequately reflect the 
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pathophysiology of the human myocardial infarction 
consequent to longstanding coronary artery disease. 
A second concern over the use of animal models to study 
human myocardial pathophysiology stems from observed 
variations in hemodynamics and myocardial blood flow under 
different experimental conditions (108). Thoracotomy, 
pericardiotomy and pentobarbital anesthesia have been shown 
to increase heart rate by more than 100% and myocardial 
perfusion by more than 30% over closed-chest unanesthetized 
dogs (17). These variations in hemodynamic parameters may 
alter experimental results and thus further complicate 
attempts to extend conclusions based on studies in animals 
to our understanding of human disease. In the present study, 
although anesthesia was not witheld, a closed-chest 
preparation was used to avoid any potential adverse 
hemodynamic affects not directly related to the induced 
myocardial ischemia. 
Analysis of Results: 
In this study we have demonstrated that quantitatively 
and statistically significant differences in absolute 
myocardial blood flow exist between histochemically 
distinct regions of myocardium following a three hour 
closed-chest LAD occlusion in the anesthetised dog. In 
addition, our data indicate that regional perfusion within 
these histochemically defined zones after three hours of 
occlusion is similar to that observed shortly following 
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occlusion, suggesting that regional myocardial blood flow in 
the dog may remain relatively constant during the initial 
three hours of ischemia. 
At three hours of LAD occlusion the area at risk and 
the area of necrosis were found to be variable from animal 
to animal (see table 5). This is in accordance with the 
findings of Marcus, et al. (69), and Reimer, et al. (91), 
and likely results from variations in vasculature and 
collateral supply between animals. The mean area of 
necrosis was similar in size to that reported by Costantini, 
et al. (19) who used a closed-chest, three hour occlusion 
with reperfusion (12% compared to 14%), and represented 44% 
of the area of ischemia, similar to the finding of Vokonas, 
et al. (116), who reported 40% in an open-chest 24 hour 
occlusion with larger absolute areas of ischemia and 
necrosis. Occlusions of greater than three hours in both 
open- and closed-chest models have been shown to produce 
larger infarcts (19,31,91,92,116), consistent with the 
assumption that at three hours necrosis is in the 
evolutionary stage and the area at risk contains potentially 
salvageable myocardium. As described by others (47,53,69, 
91,122), in all dogs with infarcts (8 of 9), the area of 
necrosis was primarily subendocardial, occupying the central 
region of the area at risk. Larger infarcts extended 
laterally and transmurally. 
Regional myocardial perfusion data obtained using the 
radiolabeled microsphere technique demonstrated that within 
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the occluded vascular territory, or area at risk, there 
exists heterogeneity in both flow reduction and degree of 
ischemic injury. Measurements of regional myocardial blood 
flow were in agreement with the findings of others for both 
normal and necrotic tissue (8,50,91,97,116), demonstrating 
severe reductions to the central necrotic zone, with 
increasing flow to more peripheral regions of ischemia. As 
suggested by many, we have found that gradients 
(53,88,90,101,111,116), rather than sharp distinctions 
(41,48,52,61) in flow and degree of injury exist between 
normal and abnormal tissue within the area at risk. 
The sharp distinctions found by some investigators may 
be the result of prolonged periods of ischemia (>24 hours), 
and likely do not reflect events in the early infarct. 
Marcus, et al. (69), while arguing against the presence of a 
"geometrically well defined 'buffer zone'" within the area 
at risk, nevertheless demonstrate with microsphere studies 5 
minutes after occlusion a heterogeneity of flow to 
myocardium adjacent to severely ischemic regions. 
Furthermore, their definition of ischemic segments is based 
on values for regional perfusion without confirmation by 
histologic techniques. 
Histochemically, the area at risk can be divided into 
three distinct regions (fig. 5). These include a central 
area of necrosis, a zone of ischemia without necrosis, and a 
peripheral region of myocardium within which the only 
ultrastructural abnormality is the presence of lipid 

-25- 
droplets. While preocclusion flows were similar in all 
regions, post-occlusion flows substantiated the 
histochemical findings of worsening ischemia from the 
periphery of the area at risk to the central area of 
necrosis. Myocardium which was underperfused but not 
ischemic received 68 ml/min/lOOgm, compared to 88 
ml/min/lOOgm for normal myocardium (p<0.05). Perfusion to 
the zone of ischemia without necrosis was 26 ml/min/lOOgm, 
both quantitatively and statistically significantly 
different from normal myocardium (p<0.001), underperfused 
but not ischemic myocardium (p<0.005) and necrotic 
myocardium (p<0.005). The central zone of necrosis 
demonstrated the lowest flows, receiving only 6 ml/min/lOOgm 
(p<0.001 compared to both underperfused but not ischemic and 
normal myocardium). The presence of lipid droplets in 
myocardium without histochemical or ultrastructural evidence 
for glycogen loss or irreversible injury is indicative of 
impaired fatty acid metabolism, the pathway most sensitive 
to mild hypoxia. This histologic suggestion of mild ischemia 
is supported by data from our microsphere studies of this 
region, which quantitate only mild reductions in blood flow 
to the tissue samples from which these biopsies were taken. 
Previous histologic investigations as well as PET studies 
similarly demonstrate abnormalities in lipid metabolism at 
the margins of ischemic beds (7,30,37,65,103,105-108,110). 
These results demonstrate that the use of monstrel blue dye 
in conjunction with PAS and TTC stains can define regions 
I ; 1 
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between normal and necrotic myocardium in which varying 
degrees of ischemia are manifest as varying degrees of 
ischemic injury, and that the perfusion deficits in these 
regions can be quantified by using the radiolebeled 
microsphere technique. 
Importantly, the evolution of injury during the three 
hour occlusion is not accompanied by an attenuation in 
perfusion. Rather, blood flow in each zone is similar at 20 
minutes and three hours, suggesting that perfusion remains 
relatively constant through the duration of the vascular 
occlusion. This is in accordance with the observations of 
Lavalee, et al. (61) who describe similar invariance in 
regional perfusion from 1 hour to 24 hours of ischemia in 
the baboon model, and of Sakai, et al. (99) who report 
equivalent flows at 15 minutes and 2 hours post-occlusion. 
In contrast, the zone of infarction, or region of 
irreversible ischemic injury, expands during the initial 
hours of coronary artery occlusion (30,91). Combined these 
two observations suggest that the "wavefront" expansion of 
an infarct as described by Reimer et al. (90,91) is not the 
result of changing myocardial perfusion, but instead is a 
function of the duration of fixed, limited perfusion. As 
the ischemic injury progresses, it may be argued that the 
demand on adjacent myocytes increases (12), and that 
myocardial oxygen demand therefore increases. Given a fixed 
oxygen supply, as suggested by our results, these cells 
would become relatively more ischemic and may progress to 
irreversible injury and necrosis. Whether an expanding 
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infarct is a function of duration of ischemia, changing 
metabolic demands, or both cannot be answered here, but our 
data indicate that the culprit is not futher attenuation in 
flow beyond the drop evident within the first 20 minutes of 
coronary artery occlusion. 
The existence of gradients of flow and heterogeneity of 
injury within the area at risk support the concept that 
coronary artery occlusion does not result in the production 
of clearly defined necrotic and non-necrotic tissue (53). 
Early in the evolution of an infarct, two intermediate 
regions of myocardium can be identified in which the hypoxic 
insult has not caused irreversible injury, yet is 
sufficient to alter metabolic activity. These regions are 
definable by histochemical techniques and demonstrate 
quantifiable and significantly distinct reductions in blood 
flow. Given our finding of the similarity between flows to 
these regions at 20 minutes and three hours of occlusion, 
interventions designed to improve perfusion to the occluded 
vascular bed may have the potential to prevent the demise of 
ischemic but not necrotic tissue and therefore represent 
appropriate therapeutic approaches to the patient with an 
evolving myocardial infarction. 
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Methodologic Considerations: 
MICROSPHERES: The technique of measuring regional 
myocardial perfusion used in our study was described by 
Heymann, et al. (46), and is known as the reference 
withdrawal method. (For a complete discussion see appendix 
III.) This technique has been employed and validated by 
many investigators evaluating blood flow to a variety of 
tissues and organs in numerous experimental situations 
(2,49,57,68,70,81,98,101). It has been clearly established 
that distribution of 15-um microspheres is proportional to 
blood flow, and that microspheres do not recirculate, affect 
hemodynamics or alter the perfusion profile (49,98,115). 
A commonly expressed concern over the use of 
radiolabeled microspheres to evaluate organ perfusion is the 
concept of "microsphere loss" (2,3,16,63). The technique 
relies on complete trapping of microspheres within the 
microcirculation for the duration of the experiment (46). 
If microspheres are not trapped (4,14,20,24,28,74,115,125), 
or a disruption of vascular integrity (as might be seen 
during ischemia) leads to loss of the trapped microsphere 
into either the general circulation or the lymphatics 
(15,16,28,56,63,64), then the resultant post-mortem analysis 
would provide an erroneously low value for regional 
perfusion in the affected tissue. "Apparent" microsphere 
loss has been described secondary to localized tissue edema 
effectively increasing the measured weight of tissue 
segments, however these studies involve occlusions 
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considerably longer than 3 hours (92). 
Such concerns have led many investigators to study the 
phenomenon of microsphere loss by several techniques. 
Studies of prolonged ischemia (from 8 to 24 hours) using 15- 
um microspheres report significant microsphere loss in the 
region of ischemia compared to regions of normal myocardium 
(2,16,63). These studies, however, all involved open-chest 
canine models, lacked histologic validation of regions of 
ischemia, and can only be applied to studies in which the 
duration of ischemia is at least 8 hours. In a study of the 
one hour LAD occlusion in the cat, Andersen, et al. (3) 
concluded that microsphere loss was a significant source of 
error based on the divergence from unity of the ratios of 
flow in the distribution of the LAD and circumflex arteries, 
although the unity of this ratio in normal feline myocardium 
was not established. Numerous other studies on real and 
"apparent" microsphere loss have concluded that the 15-um 
microsphere is the best choice for studies of myocardial 
blood flow (14,18,28,32,46), and that microsphere loss is 
not a significant problem (4,18,23,28,77,115). 
Consistent with their conclusions, our data suggest 
that microsphere loss in the three hour occlusion does not 
significantly affect determination of myocardial blood flow. 
If significant loss from the ischemic tissues had occurred, 
then values for preocclusion flow in the normal myocardium 
should be higher than those in the ischemic and necrotic 
myocardium. As can be seen in table 7 and figure 3, this is 
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not the case: Preocclusion flow in the normal myocardium 
(114 + 12 ml/min/lOOgm) is almost identical to preocclusion 
flows in the underperfused zone (104 + 45 ml/min/lOOgm), the 
ischemic but not necrotic zone (120 + 10 ml/min/lOOgm) and 
the necrotic zone (121 + 18 ml/min/lOOgm). We can therefore 
conclude that loss of 15-um microspheres, either real or 
apparent, was not a significant factor in the determination 
of regional myocardial perfusion in this study, and should 
not be a significant consideration in the evaluation of a 
three hour occlusion in the canine model. 
A second concern with the use of microspheres relates 
to adequacy of mixing of microspheres before distribution 
into the peripheral circulation. In our study, the use of a 
closed-chest model precluded injection of the microspheres 
into the left atrium and required instead that the left 
ventricle be used. Many investigators utilize a left atrial 
catheter (which requires an open-chest preparation) for 
microsphere injection with the presumption that this results 
in improved mixing (23,63,70). Buckberg, et al. (14), have 
suggested that the uniformity of mixing is better achieved 
by using left atrial as opposed to left ventricular 
injection. However, this conclusion rested on the aberrant 
results obtained from one out of the six dogs (4 out of a 
total of 23 microsphere injections) used in their study. 
Catheter placement in the left ventricle was not verified by 
fluoroscopy, and the microspheres were not suspended in 
heparinized blood prior to injection. When the results of 
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these four injections are excluded, the remaining 19 provide 
data consistent with the conclusion that there is no 
difference in mixing between left atrial and left 
ventricular injection sites. Additional evidence for the 
adequacy of mixing is offered by Hoffbrand, et al. (49) who 
used left ventricular injection of radioactively labeled 
microspheres to study the distribution of cardiac output and 
organ blood flow in the monkey. To improve mixing, we 
suspended the microspheres in a 5 to 6 ml sample of 
heparinized blood prior to injection into the left ventricle 
and insured position of the pigtail catheter in the apex of 
the left ventricle. 
HISTOCHEMICAL TECHNIQUES: Triphenyltetrazolium 
chloride (TTC) stain was used to demarcate necrotic regions 
of myocardium. As outlined by Fishbein, et al. (31), TTC 
forms a red precipitate in the presence of intact 
dehydrogenase enzyme systems. Areas of necrosis lack 
dehydrogenase activity and therefore fail to stain. The use 
of markers for enzyme activity to delineate regions of 
necrosis is supported by the finding that histochemical 
evidence of enzyme loss occurs after evidence of glycogen 
loss (30) and therefore represents more severe ischemic 
injury (5,59,66,110). This suggests that only those regions 
of myocardium which have become irreversibly injured and 
destined for necrosis show loss of enzyme activity. The 
validation of this technique by Fishbein, et al. (31) is 
supported by our finding that the classification of 
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myocardium into necrotic and non-necrotic regions based on 
TTC staining was consistent with subsequent ultrastructural 
examinations. 
The periodic acid-Schiff stain (PAS), which stains 
tissue pink in the presence of glycogen or glycoproteins, 
has been used by many investigators to delineate ischemic 
tissue (30,111). Digestion with amylase prior to staining 
abolishes positive staining due to glycogen and thus 
confirms its presence in the stained sections. As discussed 
in the introduction, ischemia is characterised by an 
inadequate supply of oxygen to meet metabolic demand, and 
results in a shift from aerobic to anaerobic metabolism 
(78,80,121). This shift decreases the energy yield and 
quickly consumes available free glucose, leading to 
increased utilization of glycogen stores (104). The 
resulting loss in tissue glycogen content occurs much 
earlier than the morphologic changes associated with 
irreversible injury (53,54) and therefore serves as a useful 
marker for early ischemia. Thus, the PAS stain can be used 
on giant histologic sections to identify grossly the 
topographic boundary of ischemic myocardium. 
The third marker used in our studies was monastrel blue 
dye. As demonstrated by others (55,91), in vivo injection 
of this dye into the circulation marks the perfused tissue 
by staining it bright blue. Post-mortem analysis identifies 
the occluded vascular territory by its lack of blue 
staining. 
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In addition to other studies validating the use of 
these histologic techniques, our approach included 
validation by comparison with electron microscopic studies 
of tissue specimens. The location of each tissue sample was 
accurately recorded by photographing the heart slices, and 
subsequent ultrastructural analysis confirmed conclusions 
reached by histochemistry. 
SIGNIFICANCE TESTING: As outlined in the materials and 
methods section, a non-paired two-tailed Student's t-test 
was used for statistical comparisons. Using a significance 
level (alpha) of 0.05, comparison between population means 
for all values of regional myocardial perfusion in the 
normal, underperfused but not ischemic, ischemic but not 
necrotic and necrotic zones at three hours post-occlusion 
yielded P values less than the established limit for 
statistical significance. Because mean myocardial blood 
flow was obtained independently for each zone prior to 
comparison between population means, considerations of 
multiple t-test analyses do not apply (1). The experimental 
design dictated division of samples into different, 
independent groups prior to analysis, rather than 
stratification of groups for purposes of statistical 
comparison. 
A type I error arises from multiple comparisons for 
each variable between various subgroups within an 
experimental population, as would be observed in a large 
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clinical trial (1). Increasing the number of such 
comparisons consequently increases the probability that a 
statistically significant difference would be observed when 
none actually exists. Because results in this study are 
based on comparisons of one variable between several 
independent groups rather than post-experiment 
stratifications of the same group, we are not at risk of 
committing a type I error. This would not be the case if, 
for example, we were to compare mean regional perfusion 
between all animals in an attempt to elucidate significant 
differences. 
Correction for the possibility of a type I error can be 
accomplished by performing the Bonferroni procedure (1). 
Given an initial significance level of alpha, an "adjusted" 
significance level (alpha*) can be calculated as 
alpha 
alpha* = -*- 
k 
where k represents the number of comparisons, or t-tests, to 
be performed between the groups. In order for a comparison 
to achieve statistical significance, the P value must now be 
less than alpha*. 
Although application of this procedure is not required 
to avoid a type I error in analysis of the results from this 
study, it nevertheless can be performed. Comparisons 
between population means for all four groups (normal, 
underperfused but not ischemic, ischemic but not necrotic 
and necrotic) total six (k=6). This establishes a new 
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significance level (alpha*) of 0.05/6 or 0.0083. As 
discussed above, all performed t-tests between these 
population means gave P values of <0.005 or <0.001 with the 
exception of the comparison between the normal and 
underperfused but not ischemic zones (p<0.05). Excluding 
this latter result, the comparisons remain statistically 
significant given the adjusted significance level of <0.008. 
In concluding that the difference between mean 
myocardial blood flow to the normal and to the underperfused 
but not ischemic zones is not statistically significant 
based on the Bonferroni procedure, care must be taken to 
avoid committing a type II error. This error is the 
consequence of concluding a lack of statistical significance 
based on the P value calculated from population means for 
groups with small sample sizes (n=3 in the underperfused but 
not ischemic group) (25). Assuming the population mean 
calculated from the given number of samples is 
representative of the true value, additional samples would 
alter the population mean minimally yet narrow the standard 
deviation and decrease the calculated P value dramatically. 
Mean myocardial blood flow within the normal zone at 
three hours was 88 ml/min/lOOgm and mean flow in the 
underperfused but not ischemic zone was 68 ml/min/lOOgm. As 
illustrated in figure 3, these differences, although they do 
not reach statistical significance when the Bonferroni 
procedure is performed, are quantitatively impressive. 
While care must be taken to avoid committing a type I error, 
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so too should we not ignore the quantitative differences 
between these population means, i.e. commit a type II error 
in concluding a lack of significance based on small sample 
size. 
Although comparisons between three hour post-occlusion 
flows in the four sample groups considered here reveal 
differences which are both quantitatively and statistically 
significant, performance of the Bonferroni procedure 
(however applicable) demonstrates the need for large sample 
sizes when comparing population means. Unlike larger 
clinical trials, the number of samples in each group could 
not be dictated in this experimental design, and was 
dependent on the variability of ischemic injury between 
animals. While the resulting comparisons reach statistical 
as well as quantitative significance, increasing the sample 
size by studying more animals would surely decrease the 
standard errors of the means and the corresponding P values, 
illustrating even more convincing differences than the ones 
observed. 
ZONE DISCRIMINATION: Because of the large size of each 
sample compared to the size of the ventricle, discrimination 
between the subtle differences in staining characteristics 
of adjacent myocardium was less than perfect. Most samples 
contained portions "contaminated" by their inclusion into 
more than one zone as identified by our histologic 
techniques. By assigning each sample a value between 0 and 
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1 for each stain, the degree to which a given sample 
represented tissue from more than one zone could be assessed 
quantitatively and used in the analysis of the perfusion 
data. By limiting analysis to only those samples without 
any signs of "contamination", only two groups (normal 
myocardium and necrotic myocardium) contained enough 
samples to be meaningfully included in the results. 
Consequently the criteria for inclusion into the various 
groups were "expanded" to include a small amount of 
"contamination." The resulting increase in sample size in 
the underperfused but not ischemic zone and the ischemic but 
not necrotic zone provided enough data from which to draw 
conclusions. Similar "expansion" was also done for the 
group containing samples from necrotic regions of 
myocardium. 
Comparison of the mean values for regional perfusion 
before and after "expansion" indicates that while the 
resulting values for blood flow are different, these 
differences are relatively small (tables 6 and 7). This is 
particularly noticeable in the TTC negative (necrotic) 
group. Mean myocardial blood flow values prior to occlusion, 
20 minutes post-occlusion and three hours post-occlusion 
before "expansion" of sample groups were 126 + 13, 9+2 and 
4 + 2 ml/min/lOOmg (n=4). After "expansion" they were 121 + 
18, 8+3 and 6+3 ml/min/lOOgm (n=5). This suggests that 
altering the criteria to allow for inclusion of samples with 
<20% and >80% instead of 0% and 100% staining specificity 
. 
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adds the benefit of increased sample size without 
sacrificing accuracy of representation. 
While including minimally "contaminated" samples 
permitted incorporation of additional measurements into the 
calculations of flow, the majority of underperfused samples 
remained unclassified due to significant heterogeneity of 
staining. These samples were included in the results by 
creating "mixed" categories which contained those samples 
exhibiting between 20% and 80% staining. Calculations of 
mean myocardial blood flow in these groups demonstrate a 
gradient of flow corresponding to the degree of injury 
similar to that for the "pure" groups. Because of the 
significant contamination of these samples, however, one 
sample could contain such a variety of flows that 
quantitative comparison with the "pure" groups would be 
without meaning. Hence, these results can be used only to 
support the likelihood that a gradient of flow exists within 
the area at risk. 
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CONCLUSION 
In this study we have been able to demonstrate that a 
three hour LAD occlusion in the closed-chest canine model 
does not result in clearly differentiated normal and 
abnormal zones. Rather, a heterogeneity of injury is found 
corresponding to the degree of flow reduction. Moreover, 
the similarity between myocardial perfusion at three hours 
and at 20 minutes after occlusion leads to the conclusion 
that flow reduction may remain constant in the early hours 
of ischemia. Because there is significant variation in the 
degree of injury between necrotic and normal tissue, it is 
not sufficient to divide the area at risk into normal and 
abnormal zones. There exist intermediate zones in which the 
degree of ischemic injury can be illustrated with 
histochemistry and the blood flow reduction can be 
quantitated with radiolabeled microspheres. This implies 
that significant regions of myocardium could benefit from 
interventions designed to improve perfusion. Clinically, 
the challenge is to evaluate a patient with chest pain for 
the presence of compromised tissue which is not necrotic, 
yet lies within the area at risk. Such myocardium is 
characterized by varying degrees of reduced blood flow which 
are manifest as differences in the severity of metabolic 
damage. The perfusion deficit is the same 20 minutes and 
three hours following coronary artery occlusion, and hence, 
interventions despite inconclusive clinical results, 
■ 
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designed to restore myocardial blood flow are appropriate 
therapeutic maneuvers in attempting to limit myocardial 
infarct size. 
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APPENDIX I 
Regional Perfusion in the Normal Canine 
Left Ventricle 
Rather than exhibiting a uniform regional perfusion 
across the entire myocardium, the normal canine left 
ventricle has variations in perfusion from apex to base, and 
from subendocardium to subepicardium. By utilizing only the 
data for regional myocardial blood flow obtained with the 
injection of the first set of radioactive microspheres 
(prior to occlusion), variations in blood flow in the 
normal, non-ischemic left ventricle can be elucidated. As 
discussed above, microsphere loss from ischemic tissue was 
not felt to be a significant factor in affecting 
determinations of flow, and therefore values for 
preocclusion flow should not reflect the subsequent ischemic 
insult. 
Similar to the results discussed in the body of this 
study, regional myocardial perfusion was calculated as a 
"mean of means" for each group. All samples were included 
in the calculations as prior to occlusion there are no 
abnormal "zones." Instead of dividing samples into groups 
based on heterogeneity of injury, they were divided into 
groups based on location. These include slice one (apex), 
slice three or slice five (base), and subepicardium, 
mesocardium or subendocardium for each slice. Slice 1, the 
apical slice, was too small to divide into three transmural 
therefore there is no "mesocardial" group. segments, 
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Results are shown in table 9, and are expressed as mean + 
standard error. 
Analysis of these results illustrates that apical 
subendocardium receives the greatest blood flow (148 + 37 
ml/min/lOOgm.) while the basal subepicardium receives the 
least (80 + 9 ml/min/lOOgm.) (p<0.001). As suggested by 
others, these results indicate that perfusion decreases from 
apex to base (69) and from subendocardium to subepicardium 
(23,61). Blood flow across normal myocardium is therefore 
not uniform but preferentially distributes to tissues 
supplied by terminal vessels. Experimentally as well as 
clinically, these are the regions of myocardium which 
consistently demonstrate the most severe ischemic injury; 
while flow in the absence of pathology may be high, 
occlusion of a coronary artery reduces flow most 
dramatically to the distal arterioles. 
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APPENDIX II 
Defining a "Control" Flow 
Several approaches may be utilized in the definition of 
a "control" flow for comparison to the regional perfusion in 
areas of interest. In order to express myocardial blood 
flow as a "percent of control" the investigator must first 
define exactly what is being used as the "control." Among 
the many options is the use of a mean value for preocclusion 
flow throughout the entire myocardium. While standardized, 
this model encounters difficulty when one appreciates the 
normal variability in regional flows from apex to base and 
subendocardium to subepicardium (see appendix I). 
Accordingly, the control values can be subdivided into 
subendocardial and subepicardial, apical and basal 
categories. Subsequently, the post-occlusion values for an 
apical subendocardial segment would be expressed as a 
percent of the preocclusion mean for all apical 
subendocardial segments. Similarly, mean post-occlusion 
flows for a basal subepicardial segment would be expressed 
as a percent of the mean preocclusion flow in all basal 
subepicardial segments. 
A second option is to use each sample as its own 
control, comparing the post-occlusion flow to the 
preocclusion flow in the same sample (101). This model 
corrects for the variability in normal myocardium by 
assuming regional perfusion to be dependent on regional 
. 
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needs. The results of applying this method of normalizing 
flow data to regional perfusion determined in this study are 
shown in table 10. Flows in the necrotic, ischemic but not 
necrotic and normal zones are almost identical to the 
absolute values shown in table 7. Results for the 
underperfused but not ischemic zone however are considerably 
different. This is primarily the result of data from dog 
#6, with flows at 20 minutes of 167 + 100% and at three 
hours of 176 + 109% (n=2). The extremely large standard 
deviation with a small n indicates the probable 
unreliability of these values in this animal. Exclusion of 
this animal yields 20 minute and three hour flows of 60% and 
64% respectively, almost identical to the results in table 
7. 
The third option is to consider that the "control" flow 
varies temporally during the experiment; myocardial needs 
prior to occlusion are different than 3 hours post¬ 
occlusion. Regional perfusion is therefore expressed as a 
percentage of flow in the "normal" myocardium at the same 
point during the experiment. "Control" flow at three hours 
is defined as the mean blood flow in the segments of 
myocardium metabolically, histologically and functionally 
without evidence of ischemic injury at three hours. This 
model has the advantage of incorporating into the results 
concepts of changing demand on myocardium following the 
stress of an ischemic injury. Table 11 contains the flow 
data from this study expressed as a percent of simultaneous 
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flow in normal regions of myocardium. As with the data in 
table 10, comparison to the results shown in table 7 reveals 
little difference in the magnitude of the values for each 
determination. 
In this study flow data are expressed as absolute 
values rather than as "% of control." This was done to 
avoid the complexities of interpretation and to present the 
data in a more straightforward fashion. 
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APPENDIX III 
Determination of Regional Myocardial Perfusion 
with Radionuclide Labeled Microspheres 
Background: 
Attempts to accurately measure distribution of cardiac 
output and organ blood flow were greatly enhanced with the 
advent in 1967 of plastic microspheres labeled with 
radioactive isotopes (98). Earlier studies of the 
circulation employed a variety of indicator particles which, 
while useful, were limitted in their application by 
inherent sources of potential error. As discussed by Wagner, 
et al. (119) and Heymann, et al. (46), the injection of 
particulate tracers into the vascular compartment was 
introduced by Pohlman in 1909 (85), who employed starch 
granules to trace blood flow patterns in the fetal pig. 
Glass microspheres, initially used by Prinzmetal, et al. 
(86,87) to study vascular anastomoses, were later bombarded 
with neutrons, converting the sodium in the glass into 
24 
radioactive Na (21,36,67). Following injection into the 
vascular compartment, this produced localized tissue 
radiation presumably proportional to blood flow. Labeling 
ceramic microspheres with radionuclides (40,51,124) applied 
the same principle to the study of the circulation but 
shared the disadvantage that both particles were 
considerably heavier than the erythrocyte, and therefore 
sedimented too rapidly for dependable use (46). 
. 
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Macroaggregates of albumin labeled with radioactive iodine 
and, more recently, dextran particles have also been 
developed (35,44,96,117-119,126), but the radiolabeled 
plastic microsphere, with a reliable uniformity in size, 
ready availability and specific gravity close to that of 
serum, has assumed the most prominent role in the study of 
the circulation. 
"Carbonized Microspheres:" 
Known as "carbonized plastic tracer microspheres," they 
have a specific gravity of approximately 1.3 (compared to 
about 1.05 for whole blood) and are composed of an inert 
plastic into which the radionuclide is incorporated (46). 
The number of counts-per-minute (cpm) is therefore dependent 
on microsphere size. They are available in sizes ranging 
from 2-4 to 50-um in diameter and come suspended in 10% 
dextran with 0.19% by volume Tween-80 (polyoxyethylene 80 
sorbitan monooleate, a detergent to prevent clumping). 
Regional perfusion at different time intervals in the 
same animal can be determined by using microspheres labeled 
with different radionuclides. Using a multichannel pulse- 
height gamma counter to analyse the tissue samples, peaks 
from the different isotopes can be identified and 
quantitated. The contribution of each isotope can be 
determined from the resulting spectral profile either 
manually or through the use of computer analysis. The 
mathematics are explored in detail by Heymann, et al. (46). 
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Principles of Use: 
As outlined by several authors (4,14,23,32,46,68,98,115, 
125), obtaining accurate and precise results from the use of 
radiolabeled microspheres depends upon satisfying the 
following principles: 
1) They must be well mixed prior to their 
distribution into the systemic circulation; 
2) the distribution of microspheres must be 
proportional to blood flow; 
3) they must be completely trapped during their 
first transit through the circulation; 
4) they must remain trapped in the capillary bed 
for the duration of the experiment; 
5) their use must not alter hemodynamics or flow 
profiles; 
6) they must be biologically inert and retain 
their radioactive label; and 
7) there must be enough microspheres per sample to 
insure random variation in distribution 
introduces only negligible error. 
These principles dictate that care must be taken in 
choosing the method for injection and the size and number of 
microspheres to be injected. Both left ventricular and 
left atrial sites have been shown to provide for adequate 
mixing (14), while the number and size of the injected 
particles depends on the tissue to be studied. By assuming a 
Poisson distribution of microspheres, Buckberg et al. (14) 
and others (46) have demonstrated that no less than 384 
microspheres per sample are required to achieve a 
distribution variability of less than 10% at the 95% 
. 
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confidence level. Given that the canine ventricle receives 
~1% of the cardiac output, injection of 3,000,000 particles 
into the circulation should result in trapping of -30,000 
across the myocardium, sufficient for accurate and precise 
measurements of blood flow. 
Choice of an appropriate size microsphere is dependent 
on several variables. The particles must be large enough to 
trap in capillaries and not shunt or dislodge during the 
experiment, yet must be small enough to travel in a pattern 
similar to erythrocytes. Larger particles have been shown 
to migrate axially more rapidly than smaller ones (83,109), 
while smaller ones behave more like red cells (46). Studies 
using frozen arterial sections demonstrate that 68% of 50-um 
microspheres are "found within half the radial distance from 
the center of the artery, and 89% within three-fourths of 
the radial distance from the center" (81). This is in 
contrast to the behavior of red cells, which, except for a 
slight increase in concentration along vessel walls, are 
more evenly distributed (46). Increased particle size may 
therefore result in preferential streaming of microspheres 
to distal vessels over those that arise more proximally, 
leading to inaccurate measures of blood flow distribution 
within organs. Smaller particles, while behaving more like 
erythrocytes, are at greater risk for both failure to trap 
during the first pass and shunting across arterial beds. 
Many investigators addressing this problem have concluded 
that the 15-um microsphere represents an ideal compromise, 
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with compelete trapping, less than 1% shunting and 
distribution more closely approximating that of the red cell 
(4,14,28,32,46). 
Calculation of Blood Flow: 
Assuming adequate mixing, complete trapping without 
particle loss and appropriate distribution, the number of 
microspheres present in a given sample of tissue should be 
proportional to the blood flow to that sample. The number 
of microspheres present (q) at time t, can be calculated as: 
q(t) / C (t) dt 
o 
where f is the blood flow to the sample and C(t) is the 
concentration of microspheres in the arterial blood (57). 
Trapping of microspheres by the tissues performs a 
physiologic integration of the variation in concentration 
with time, and because C(t) begins at zero prior to 
injection and returns to zero after complete trapping, this 
integral has finite limits. If the total number of 
microspheres injected (q') and the cardiac output (C.O.) are 
known, the above equation can be rewritten as (14): 
Using these two equations to solve for q(t) gives: 
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q' 
q (t) = f * 
c.o. 
Converting number of microspheres to counts-per-minute (cpm) 
detected yields: 
total cpm injected 
sample cpm = sample blood flow * ——-- 
cardiac output 
Rearranging: 
sample cpm 
sample blood flow = C.O. *----— 
total cpm injected 
This method enables the experimenter to calculate blood 
flow to any sample but requires that both the cardiac output 
and the total radiocativity injected are known. A 
modification of this technique, known as the "systemic 
arterial reference sample technique" was introduced in 1968 
(68) and subsequently described by several authors 
(4,14,23,46). Cardiac output represents the blood flow to 
the entire animal, while the total number of microspheres 
injected is the total number trapped in the entire animal. 
Analogously, the number of microspheres in any one organ 
could be substituted for q' if the blood flow to that organ 
were known. In this case the blood flow to the organ is 
analogous to the cardiac output and is termed the "reference 
blood flow" to the "reference" organ. Thus: 
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I(t) = 
r 
f 
r 
0 
/ C(t) dt 
where I(t) is the radioactivity in the reference organ and 
r 
f is the blood flow to the reference organ. Rearranging as 
r 
above: 
I 
s 
sample blood flow = f * - 
r I 
r 
where I is the total cpm in the sample and I is the total 
s r 
cpm in the reference organ. Withdrawing blood from an 
arterial catheter at a known rate creates a "surrogate" 
organ, experimentally integrating C(t) over time into a 
reservoir of arterial blood. Total radioactivity in the 
arterial sample and the withdrawal rate can therefore be 
substituted for I and f respectively. In this manner 
r r 
blood flow to any tissue sample can be calculated as: 
I 
s 
sample blood flow = f *  --—■ 
a I 
a 
where f is the withdrawal rate of the arterial reference 
a 
sample and I is the total cpm in the withdrawn blood, 
a 
Provided the principles of use are observed, the blood 
flow to any sample of tissue can be determined accurately 
and precisely. Introduction of the "reference withdrawal 
method" has made this determination simpler and afforded 
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investigators broader applications. In this study, the use 
of radionuclide labeled microspheres enabled evaluation of 
differences in regional myocardial perfusion between 
morphologically delineated zones of differing ischemic 
injury early in the evolution of a myocardial infarction. 
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-68- 
Figure 2a: Example of Monastrel Blue Dye Staining Used to Delineate 
Underperfused Myocardium; Dog #6 

-69- 
Fiaure 2b: Example of PAS Staining of Giant Histologic Sections Used to 
Delineate Glycogen-Depleted, Ischemic Myocardium; Dog #7 

-70- 
Fig u re 2c: Example of TTC Staining Used to Delineate Necrotic 
Myocardium: A Large Transmural Infarct; Dog #9 
Note: A) Margin of Blue Dye Staining Peripheral to Margin of TTC Staining (arrows), and 
B) Sites of E.M. Biopsies 
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| Prior to Occlusion 
Myocardium not Ischemic not Necrotic Myocardium 
n=9 n=3 n=3 n=5 
Figure 3: Mean Myocardial Blood Flow to Normal, Underperfused but 
not Ischemic, Ischemic but not Necrotic and Necrotic Myocardium 
prior to and following a 3 hour LAD Occlusion 
'Mean (ml/min/IOOgm) ± S.E.M. 

72 
Figure 4a: Ultrastructural Findings in Normal Myocardium 
* 
73 
Figure 4b; Ultrastructural Findings in Tissue from the Underperfused Zone 
Note: Absence of cell swelling, normal mitochondria, no loss of glycogen, but increased lipid 
droplets (arrows) 

74 
Figure 4c: Ultrastructural Confirmation of Ischemia without Necrosis in 
the Glycogen-Depleted Zone 
Note: Intracellular edema, mild swelling of mitochondria, wide l-bands and loss of glycogen 

-75- 
Fiaure 4d: Ultrastructural Confirmation of Necrosis in TTC Negative 
Myocardium 
Note: Clumping and margination of nuclear chromatin, swollen mitochondria with matrix 
densities, and disruption of mitochondrial and sarcolemmal membranes 
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NECROTIC ZONE 
Mean Size = 12% of LV 
Mean Flow = 6 ± 3 ml/min/1 OOmg 
mm ISCHEMIC BUT NOT NECROTIC ZONE 
Mean Size = 15% of LV 
Mean Flow = 26 ± 3 ml/min/1 OOmg 
UNDERPERFUSED BUT NOT ISCHEMIC 
OR NECROTIC ZONE 
Mean Size = 7% of LV 
Mean Flow = 68 ± 5 ml/min/1 OOmg 
Figure 5: Schematic Representation of Histochemically Delineated 
Regions of Myocardium Showing the Central Necrotic zone within an 
Ischemic zone, within an Underperfused zone 
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